LeadIQ logo
Learn more at LeadIQ.com

Insights

Acquisition by Unchained Labs Recent acquisition by Unchained Labs presents an opportunity for cross-selling to existing Unchained Labs customers who might benefit from NanoView Biosciences' precision medicine products and exosome analysis solutions.

Product Launch - ExoView R200 The launch of ExoView R200, NanoView Biosciences' next-generation platform for extracellular vesicle detection, opens up avenues for targeting researchers and institutions looking for sensitive and advanced EV characterization tools. This presents a sales opportunity to showcase the enhanced capabilities of the new platform.

Strategic Partnerships with Medical Centers Collaborations with institutions like Beth Israel Deaconess Medical Center demonstrate NanoView Biosciences' involvement in cutting-edge research. Sales teams could leverage these partnerships to align with medical centers seeking innovative biomarker characterization solutions for cancer therapies, potentially leading to new client acquisitions.

Scientific Advisory Board Appointments The addition of renowned experts like Prof. Jan Lötvall and Mark Plavsic to NanoView Biosciences' Scientific Advisory Board enhances the company's credibility and expertise in the industry. Sales representatives can use these appointments to bolster trust with potential clients seeking advanced exosome analysis solutions.

Technology Platform Innovations NanoView Biosciences' novel technology platform for exosome identification and characterization sets it apart in the market. Sales teams can capitalize on this innovative edge to attract researchers and biotech companies looking for disruptive technologies in the field of precision medicine and cellular communication.

Similar companies to NanoView Biosciences

NanoView Biosciences Tech Stack

NanoView Biosciences uses 8 technology products and services including Linkedin Ads, Cloudflare, RSS, and more. Explore NanoView Biosciences's tech stack below.

  • Linkedin Ads
    Advertising
  • Cloudflare
    Content Management System
  • RSS
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Google Tag Manager
    Tag Management
  • Materialize CSS
    UI Frameworks
  • YouTube
    Video Players
  • Twitter
    Widgets

Media & News

NanoView Biosciences's Email Address Formats

NanoView Biosciences uses at least 1 format(s):
NanoView Biosciences Email FormatsExamplePercentage
FLast@nanoviewbio.comJDoe@nanoviewbio.com
47%
First.Last@nanoviewbio.comJohn.Doe@nanoviewbio.com
3%
FLast@nanoviewbio.comJDoe@nanoviewbio.com
47%
First.Last@nanoviewbio.comJohn.Doe@nanoviewbio.com
3%

Frequently Asked Questions

Where is NanoView Biosciences's headquarters located?

Minus sign iconPlus sign icon
NanoView Biosciences's main headquarters is located at 1380 Soldiers Field Rd Boston, Massachusetts US. The company has employees across 2 continents, including North AmericaEurope.

What is NanoView Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact NanoView Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NanoView Biosciences's official website and social media links?

Minus sign iconPlus sign icon
NanoView Biosciences's official website is nanoviewbio.com and has social profiles on LinkedIn.

What is NanoView Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
NanoView Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NanoView Biosciences have currently?

Minus sign iconPlus sign icon
As of April 2022, NanoView Biosciences has approximately 44 employees across 2 continents, including North AmericaEurope. Key team members include Associate Director Of Administration: K. L.Associate Director Of Engineering: S. S.Manager, Engineering Services: R. N.. Explore NanoView Biosciences's employee directory with LeadIQ.

What industry does NanoView Biosciences belong to?

Minus sign iconPlus sign icon
NanoView Biosciences operates in the Biotechnology Research industry.

What technology does NanoView Biosciences use?

Minus sign iconPlus sign icon
NanoView Biosciences's tech stack includes Linkedin AdsCloudflareRSSWP EngineGoogle Tag ManagerMaterialize CSSYouTubeTwitter.

What is NanoView Biosciences's email format?

Minus sign iconPlus sign icon
NanoView Biosciences's email format typically follows the pattern of . Find more NanoView Biosciences email formats with LeadIQ.

How much funding has NanoView Biosciences raised to date?

Minus sign iconPlus sign icon
As of April 2022, NanoView Biosciences has raised $10M in funding. The last funding round occurred on Oct 10, 2018 for $10M.

When was NanoView Biosciences founded?

Minus sign iconPlus sign icon
NanoView Biosciences was founded in 2015.
NanoView Biosciences

NanoView Biosciences

Biotechnology ResearchMassachusetts, United States11-50 Employees

NanoView Biosciences, is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biology of cellular communication and provide improved insight for how diseases are diagnosed, treated and monitored.

Section iconCompany Overview

Headquarters
1380 Soldiers Field Rd Boston, Massachusetts US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $10M

    NanoView Biosciences has raised a total of $10M of funding over 1 rounds. Their latest funding round was raised on Oct 10, 2018 in the amount of $10Mas a Series B.

Section iconFunding & Financials

  • $10M

    NanoView Biosciences has raised a total of $10M of funding over 1 rounds. Their latest funding round was raised on Oct 10, 2018 in the amount of $10Mas a Series B.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.